Ontario Institute for Cancer Research (OICR)
Ontario Institute for Cancer Research (OICR)
About

Our Vision

Cancer Solved Together

Our Mission

Partner with the oncology community to translate cancer research discoveries, transforming cancer care to benefit patients, and strengthening the Ontario economy.

Our Values

Excellence | Innovation | Collaboration | Impact | Responsibility | Community

The Ontario Institute for Cancer Research (OICR) is a collaborative research institute that conducts and enables high-impact translational cancer research. We help to accelerate the development of discoveries for patients around the world while maximizing the economic benefit of this research for the people of Ontario.

OICR strives to turn insights in cancer research into precision medicine innovations that are implemented into Ontario’s health system to transform patient outcomes for the better.

In collaboration with our partners in healthcare, research, government and the private sector, we:

  • Conduct cross-disciplinary cancer research in fields such as genomics, immuno-oncology, informatics, drug discovery and molecular pathology
  • Enable research in Ontario and worldwide by building collaborative networks, securely sharing data, and making tools and resources available to the research community
  • Translate our research findings to the clinic by developing clinical guidelines, supporting clinical trials and working with our strategic partner FACIT to advance the commercialization of our innovations and IP.

All our funded research goes through independent peer review and is overseen by external scientific advisory committees.

What is translational research at OICR?

At OICR, translational research is about facilitating real-world impact. This means ensuring promising cancer research discoveries are developed into new diagnostics, treatments and practices that can help people in Ontario and beyond.

Read more

Type of organization

1 office

Experience

Contract Awards
Reactome: An Open Knowledgebase of Human Pathways
National Institutes of Health (NIH) - United States
Overture: A Multi-Scale Data Platform for Cancer Genomics Research
National Institutes of Health (NIH) - United States
Introducing CI/CD Technologies to Optimize Software Development in Reactome
National Institutes of Health (NIH) - United States
Optimizing Reactome Trust
National Institutes of Health (NIH) - United States

Company Offices

  • United States
  • Toronto
  • MaRS Centre 661 University Avenue, Suite 510 Toronto, Ontario Canada, M5G 0A3